DocMorris AG (ZRSEF)
USD 39.03
(0.0%)
USD 39.03
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 866.42 Million CHF | -21.19% |
| 2022 | 1.09 Billion CHF | -13.38% |
| 2021 | 1.26 Billion CHF | -0.72% |
| 2020 | 1.27 Billion CHF | 28.91% |
| 2019 | 991.72 Million CHF | 36.5% |
| 2018 | 726.52 Million CHF | 59.06% |
| 2017 | 456.76 Million CHF | 74.65% |
| 2016 | 261.52 Million CHF | 12.04% |
| 2015 | 233.42 Million CHF | 2.33% |
| 2014 | 228.11 Million CHF | 1.33% |
| 2013 | 225.11 Million CHF | -15.32% |
| 2012 | 265.82 Million CHF | 84.0% |
| 2011 | 144.47 Million CHF | -0.55% |
| 2010 | 145.26 Million CHF | -13.72% |
| 2009 | 168.36 Million CHF | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 915.07 Million CHF | 5.62% |
| 2024 Q2 | 915.07 Million CHF | 0.0% |
| 2023 Q2 | 1.01 Billion CHF | 0.0% |
| 2023 FY | 866.42 Million CHF | -21.19% |
| 2023 Q4 | 866.42 Million CHF | 0.0% |
| 2023 Q3 | 866.42 Million CHF | -14.26% |
| 2023 Q1 | 1.01 Billion CHF | -8.09% |
| 2022 Q4 | 1.09 Billion CHF | 0.0% |
| 2022 FY | 1.09 Billion CHF | -13.38% |
| 2022 Q2 | 1.14 Billion CHF | 0.0% |
| 2022 Q3 | 1.09 Billion CHF | -3.88% |
| 2022 Q1 | 1.14 Billion CHF | -9.88% |
| 2021 Q1 | 1.25 Billion CHF | -2.12% |
| 2021 FY | 1.26 Billion CHF | -0.72% |
| 2021 Q4 | 1.26 Billion CHF | 0.0% |
| 2021 Q3 | 1.26 Billion CHF | 1.42% |
| 2021 Q2 | 1.25 Billion CHF | 0.0% |
| 2020 FY | 1.27 Billion CHF | 28.91% |
| 2020 Q1 | 1.08 Billion CHF | 9.07% |
| 2020 Q4 | 1.27 Billion CHF | 0.0% |
| 2020 Q2 | 1.08 Billion CHF | 0.0% |
| 2020 Q3 | 1.27 Billion CHF | 18.2% |
| 2019 Q3 | 991.72 Million CHF | 21.61% |
| 2019 Q4 | 991.72 Million CHF | 0.0% |
| 2019 FY | 991.72 Million CHF | 36.5% |
| 2019 Q1 | 815.46 Million CHF | 12.24% |
| 2019 Q2 | 815.46 Million CHF | 0.0% |
| 2018 Q1 | 450.44 Million CHF | -1.38% |
| 2018 FY | 726.52 Million CHF | 59.06% |
| 2018 Q4 | 726.52 Million CHF | 0.0% |
| 2018 Q3 | 726.52 Million CHF | 61.29% |
| 2018 Q2 | 450.44 Million CHF | 0.0% |
| 2017 Q1 | 266.23 Million CHF | 1.8% |
| 2017 FY | 456.76 Million CHF | 74.65% |
| 2017 Q4 | 456.76 Million CHF | -1.08% |
| 2017 Q3 | 461.76 Million CHF | 77.79% |
| 2017 Q2 | 259.72 Million CHF | -2.44% |
| 2016 Q1 | - CHF | -100.0% |
| 2016 FY | 261.52 Million CHF | 12.04% |
| 2016 Q4 | 261.52 Million CHF | 0.0% |
| 2016 Q3 | 261.52 Million CHF | 8.99% |
| 2016 Q2 | 239.95 Million CHF | 0.0% |
| 2015 Q3 | 233.42 Million CHF | 2.66% |
| 2015 Q2 | 227.37 Million CHF | 0.0% |
| 2015 FY | 233.42 Million CHF | 2.33% |
| 2015 Q4 | 233.42 Million CHF | 0.0% |
| 2015 Q1 | 227.37 Million CHF | -0.32% |
| 2014 FY | 228.11 Million CHF | 1.33% |
| 2014 Q4 | 228.11 Million CHF | 0.0% |
| 2014 Q3 | 228.11 Million CHF | 1.75% |
| 2014 Q2 | 224.2 Million CHF | 0.0% |
| 2014 Q1 | 224.2 Million CHF | -0.4% |
| 2013 Q2 | 229.73 Million CHF | 0.0% |
| 2013 Q3 | 225.11 Million CHF | -2.01% |
| 2013 Q4 | 225.11 Million CHF | 0.0% |
| 2013 FY | 225.11 Million CHF | -15.32% |
| 2013 Q1 | 229.73 Million CHF | 0.0% |
| 2012 FY | 265.82 Million CHF | 84.0% |
| 2011 FY | 144.47 Million CHF | -0.55% |
| 2010 FY | 145.26 Million CHF | -13.72% |
| 2009 FY | 168.36 Million CHF | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | 220.00 USD | -393828536.364% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 567.74 Million USD | -52.609% |
| Café Serendipity Holdings, Inc. | 1.04 Million USD | -82804.628% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 501.27 Thousand USD | -172742.469% |
| HealthWarehouse.com, Inc. | 3.2 Million USD | -26903.939% |
| LIGAND PHARMACEUTICAL INC | 787.21 Million USD | -10.062% |
| MedGen, Inc. | 0.79 USD | -109673797368.354% |
| Omni Health, Inc. | 5.53 Million USD | -15563.227% |
| Oxford Investments Holdings Inc. | 451.08 Thousand USD | -191977.033% |
| Pineapple, Inc. | 7.83 Million USD | -10951.83% |
| ScripsAmerica, Inc. | 5.64 Million USD | -15251.125% |